Cross-resistance phenotypes of fluconazole-resistant Candida species: Results with 655 clinical isolates with different methods

Diagnostic Microbiology and Infectious Disease

Volumn 26, Issue 3-4, 1996, Pages 145-148

  Stevens, David A ^a,b,c,d   Stevens, Julie A ^b  

^a Department of Medicine ^*  (United States)

^b CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CONTROLLED STUDY; CROSS RESISTANCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

EID: 0030295029     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00199-X     Document Type: Article

References (15)

1. Barchiesi FA, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG (1994) In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 38:1530-1533.
2. Brammer KW, Farrow PR, Faulkner JK (1990) Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 12(suppl 1):S318-S326.
3. Brass C, Galgiani JN, Blaschke TF, DeFelice R, O'Reilly RA, Stevens DA (1982) Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother 21: 151-158.
4. Fromtling RA, Galgiani JN, Pfaller MA, Espinel-Ingroff A, Bartlett KF, Body BS, Frey C, Hall G, Roberts GD, Nolte FB, Odds FC, Rinaldi M, Sugar AM, Villareal K (1993) Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 37:39-45.
5. Grant SM, Clissold SP (1990) Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877-916.
6. Hanson LH, Stevens DA (1992) Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion. Antimicrob Agents Chemother 36:486-488.
7. Heinic GS, Stevens DA, Greenspan D, MacPhail MA, Dodd CL, Stringari S, Strull WM, Hollander H (1993) Fluconazole-resistant Candida in AIDS patients. Report of two cases. Oral Surg, Oral Med, Oral Pathol 76:711-715.
8. Heykants J, Van Peer A, Van de Velde V, Van Rooy P, Meuldermans W, Lavrijsen K, Woestenborghs R, Van Cutsem P, Cauwenbergh G (1989) The clinical pharmacokinetics of itraconazole: An overview. Mycoses 32(suppl 1):67-87.
9. Ng TTC, Denning DW (1993) Fluconazole resistance in Candida patients with AIDS - A therapeutic approach. J Infect 26:117-125.
10. Rex JH, Bennett JE, Sugar AM, Pappas PG, Van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD, the Candidemia Study Group, the NIAID Mycoses Study Group (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325-1330.
11. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD for the NIAID Mycoses Study Group and the Candidemia Study Group (1995a) Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B for treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 39:40-44.
12. Rex JH, Rinaldi MG, Pfaller MA (1995b) Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39:1-8.
13. Stiller RL, Bennett JE, Scholer HJ, Wall M, Polak A, Stevens DA (1983) Correlations of in vitro susceptibility test results with in vivo response: Flucytosine therapy in a systemic candidiasis model. J Infect Dis 147:1070-1077.
14. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277.
15. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R (1993) Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 37:1847-1849.